These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16092097)

  • 1. Toward future therapies in progressive supranuclear palsy.
    Burn DJ; Warren NM
    Mov Disord; 2005 Aug; 20 Suppl 12():S92-8. PubMed ID: 16092097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of progressive supranuclear palsy].
    Finali G; Piccinin GL; Piccirilli M; Stefano E
    Clin Ter; 1989 Jun; 129(5):339-51. PubMed ID: 2569956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholinergic systems in progressive supranuclear palsy.
    Warren NM; Piggott MA; Perry EK; Burn DJ
    Brain; 2005 Feb; 128(Pt 2):239-49. PubMed ID: 15649952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subthalamic stimulation improves levodopa responsive symptoms in a case of progressive supranuclear palsy.
    Bergmann KJ; Salak VL
    Parkinsonism Relat Disord; 2008; 14(4):348-52. PubMed ID: 17825599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and treatment of restless legs syndrome in progressive supranuclear palsy.
    Moccia M; Picillo M; Erro R; Allocca R; Barone P; Vitale C
    J Neurol Sci; 2015 Mar; 350(1-2):103-4. PubMed ID: 25697711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amantadine-induced myoclonus in a patient with progressive supranuclear palsy.
    Yarnall AJ; Burn DJ
    Age Ageing; 2012 Sep; 41(5):695-6. PubMed ID: 22421702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational therapeutic approaches to progressive supranuclear palsy.
    Stamelou M; de Silva R; Arias-Carrión O; Boura E; Höllerhage M; Oertel WH; Müller U; Höglinger GU
    Brain; 2010 Jun; 133(Pt 6):1578-90. PubMed ID: 20472654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Steele-Richardson-Olszewski syndrome].
    Mano Y
    Nihon Rinsho; 1993 Nov; 51(11):2962-7. PubMed ID: 7903988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Review of Treatment Options for Progressive Supranuclear Palsy.
    Stamelou M; Höglinger G
    CNS Drugs; 2016 Jul; 30(7):629-36. PubMed ID: 27222018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive supranuclear palsy: a current review.
    Lubarsky M; Juncos JL
    Neurologist; 2008 Mar; 14(2):79-88. PubMed ID: 18332837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progressive supranuclear palsy (PSP)].
    Nishimiya J; Yuasa T
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):45-8. PubMed ID: 10434587
    [No Abstract]   [Full Text] [Related]  

  • 12. Progressive supranuclear palsy revisited.
    Litvan I
    Acta Neurol Scand; 1998 Dec; 98(6):73-84. PubMed ID: 9875630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of progressive supranuclear palsy and corticobasal degeneration.
    Lang AE
    Mov Disord; 2005 Aug; 20 Suppl 12():S83-91. PubMed ID: 16092096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive supranuclear palsy revisited.
    Litvan I
    Acta Neurol Scand; 1998 Aug; 98(2):73-84. PubMed ID: 9724003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excessive dopamine neuron loss in progressive supranuclear palsy.
    Murphy KE; Karaconji T; Hardman CD; Halliday GM
    Mov Disord; 2008 Mar; 23(4):607-10. PubMed ID: 18163454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current and future therapeutic approaches in progressive supranuclear palsy.
    van Balken I; Litvan I
    Handb Clin Neurol; 2008; 89():493-508. PubMed ID: 18631772
    [No Abstract]   [Full Text] [Related]  

  • 17. Progress in the treatment of Parkinson-Plus syndromes.
    Olfati N; Shoeibi A; Litvan I
    Parkinsonism Relat Disord; 2019 Feb; 59():101-110. PubMed ID: 30314846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on the treatment of tics.
    Lang AE
    Adv Neurol; 2001; 85():355-62. PubMed ID: 11530443
    [No Abstract]   [Full Text] [Related]  

  • 19. Progressive supranuclear palsy.
    Esper CD; Weiner WJ; Factor SA
    Rev Neurol Dis; 2007; 4(4):209-16. PubMed ID: 18195676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological hypersexuality induced by dopamine replacement therapy in a patient with progressive supranuclear palsy.
    Kim YY; Park HY; Kim JM; Kim KW
    J Neuropsychiatry Clin Neurosci; 2008; 20(4):496-7. PubMed ID: 19196941
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.